Insider Selling: Aehr Test Systems (NASDAQ:AEHR) Director Sells $758,271.00 in Stock

Aehr Test Systems (NASDAQ:AEHR) Director Howard Slayen sold 5,700 shares of the stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $133.03, for a total value of $758,271.00. Following the completion of the transaction, the director directly owned 140,667 shares of the company’s stock, valued at $18,712,931.01. This trade represents a 3.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Aehr Test Systems Price Performance

Shares of Aehr Test Systems stock opened at $134.06 on Monday. Aehr Test Systems has a 1-year low of $16.38 and a 1-year high of $147.40. The business’s fifty day moving average price is $92.83 and its two-hundred day moving average price is $71.76. The company has a market capitalization of $4.37 billion, a P/E ratio of -558.56 and a beta of 3.10.

Key Stories Impacting Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Institutional Trading of Aehr Test Systems

A number of hedge funds and other institutional investors have recently modified their holdings of AEHR. Freestone Grove Partners LP acquired a new stake in shares of Aehr Test Systems in the second quarter valued at $189,000. Jupiter Topco LLC bought a new position in Aehr Test Systems during the second quarter valued at about $1,172,000. AWM Investment Company Inc. acquired a new position in Aehr Test Systems during the second quarter worth about $36,004,000. Legal & General Group Plc acquired a new position in Aehr Test Systems during the second quarter worth about $2,288,000. Finally, The Manufacturers Life Insurance Company bought a new stake in Aehr Test Systems in the second quarter worth about $1,007,000. Institutional investors own 69.69% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Zacks Research raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. Lake Street Capital reissued a “buy” rating and set a $110.00 target price on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Craig Hallum restated a “buy” rating and set a $125.00 price target on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Freedom Capital raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 16th. Finally, Weiss Ratings lowered shares of Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research note on Wednesday, July 29th. Two investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Aehr Test Systems presently has an average rating of “Buy” and a consensus target price of $136.67.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.